Pharmacokinetics of GLPG2737 in Male Subjects With Cystic Fibrosis
Clinical trial NCT03450720 · COMPLETED
Trial details
- NCT number
- NCT03450720
- Sponsor
- Lakefront Biotherapeutics NV
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2017-06-28
- Primary completion
- 2017-08-16
- Enrollment
- 6
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.